A Study of Melphalan Flufenamide (Melflufen) Plus Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Memorial Sloan Kettering Cancer Center, New York

Turin Hospital Myeloma Unit, Turin

Hudson Valley Hematology Oncology, Poughkeepsie

UPMC Hillman Cancer Insitute, Pittsburgh

Hospital Universitario de La Princesa, Madrid

Hospital Universitario Fundación Jiménez Díaz, Madrid

Clínica Universidad de Navarra, Pamplona

University of Florida, Gainesville

Complejo Hospitalario de Salamanca, Salamanca

Universita di Bolognia, Bologna

CHU de Nantes, Nantes

Hospital Universitario Doctor Peset, Valencia

Karmanos Cancer Center, Detroit

RUSH, Chicago

Baylor, Dallas

CHU de Poitiers, Poitiers

Innovative Clinical Research Institute (ICRI), Whittier

Dana Farber Cancer Institute, Boston

Hospital Clinic i Provincial de Barcelona, Barcelona

Institut Català d'Oncología (ICO) Badalona, Barcelona